Elizabeth Cohen-Jonathan Moyal

5PUBLICATIONS
52CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapyPsychological methodology, design and analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 21, 2025
Clinical outcome and deep learning imaging characteristics of patients treated by radio-chemotherapy for a "molecular" glioblastoma.

Caroline Zerbib, Lucas Robinet, Soleakhena Ken

|Jan 30, 2025
Olaparib, Temozolomide, and Concomitant Radiotherapy for Partially Resected or Biopsy-Only Glioblastoma First-Line Treatment: Results from the OLA-TMZ-RTE-01 Phase I Study.

Dinu Stefan, Paul Lesueur, Justine Lequesne

|Oct 02, 2024
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.

Salah Eddine O Kacimi, Caroline Dehais, Loïc Feuvret

|Nov 03, 2023
The STEMRI trial: Magnetic resonance spectroscopy imaging can define tumor areas enriched in glioblastoma stem-like cells.

Anthony Lemarié, Vincent Lubrano, Caroline Delmas

|May 31, 2021
Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults.

Thiébaud Picart, Marc Barritault, Delphine Poncet

Pageof 1

Frequent Collaborators

2 joint publications

Ahmed Idbaïh

2 joint publications

Loic Feuvret

2 joint publications

Franck Bielle

2 joint publications

Mathilde Ducloie